Ignyte Acquisition Corp.

Status: Deal Closed
U=S+W/2 W=S@11.5
IPO Proceeds, $M $57.50M
IPO Date Jan 28, 2021
CEO David I. Rosenberg; David J. Strupp, Jr.
Left Lead EarlyBirdCapital
IPO Cash in Trust 100.0%
SPAC Tenor 21 months
IPO Sector Healthcare

Life sciences, biotechnology and healthcare

IPO Geography Global
Target Company Peak Bio
Deal Announced Apr 28, 2022
Deal Size, $M $205.38M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Oct 25, 2022
Amendment Vote TBD
Closing Date Nov 1, 2022
Formerly IGNY PKBO PKBOW

Sign up for Free Trial

No credit card required

Sign in for more on Ignyte Acquisition Corp.:

  • Structure and cap table
  • 7 directors & officers
  • 27 filings and events
  • 1 underwriters
  • 4 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
David I. Rosenberg 47 Chairman of the Board and Co-Chief Executive Officer
David J. Strupp, Jr. 52 Co-Chief Executive Officer and Director
Steven Kaplan 57 Chief Financial Officer and Director
Cheryl Cohen 54 Director
Charles Wilson, Ph.D. 56 Director
John Andrew Boockvar, M.D. 49 Director
Richard J. Rosenstock 69 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
EarlyBirdCapital BR 5,000,000 units
5,000,000 units
Up-Front UW fee 2.00 %
BCMA 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 27 filings.

Shareholders

Sign in to view shareholders 13F filing data.